Next Article in Journal
One Step at a Time: A Pediatric Case of Primary Two Staged Liver Transplantation in a Child with ESLD
Next Article in Special Issue
Normothermic Machine Perfusion as a Tool for Safe Transplantation of High-Risk Recipients
Previous Article in Journal
Nutritional Predictors of Cardiovascular Risk in Patients after Kidney Transplantation-Pilot Study
Previous Article in Special Issue
Machine Perfusion of the Human Heart
 
 
Article
Peer-Review Record

Exploring Porcine Precision-Cut Kidney Slices as a Model for Transplant-Related Ischemia-Reperfusion Injury

Transplantology 2022, 3(2), 139-151; https://doi.org/10.3390/transplantology3020015
by L. Annick van Furth 1,*, Henri G. D. Leuvenink 1, Lorina Seras 2, Inge A. M. de Graaf 2, Peter Olinga 3 and L. Leonie van Leeuwen 1
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Transplantology 2022, 3(2), 139-151; https://doi.org/10.3390/transplantology3020015
Submission received: 27 January 2022 / Revised: 7 April 2022 / Accepted: 19 April 2022 / Published: 26 April 2022
(This article belongs to the Special Issue Machine Perfusion in Organ Transplantation)

Round 1

Reviewer 1 Report

Please find the comments attached 

Comments for author File: Comments.pdf

Author Response

See the attachement.

Author Response File: Author Response.pdf

Reviewer 2 Report

This is an interesting approach to ischemia research in kidney transplantation, but it has moderate relevance to reperfusion injury. The methods proposed have its major use in studies of viability of tisue after ischemic insult, as well as testing of pharmacological treatment of the damaged tissue after CS vs HMP or NMP. The method have limited use to study outcome and functional aspects in the transplanted individual. as pointed out, the real problems arise when reperfusion starts, causing new damage to the organ that can not be studied easily using the proposed methods. I find the Dextran 40 and RBC parts not helpful. i do not see the clinical relevance. Detran 40 will stick to most surfaces and actually make oxygenation harder. Its extremely high colloid oncotic pressure will affect cells, probably even more in a slice setting. The major reason for using RBC in NMP, apart from oxygenation, is to use the buffering capacity. Since slices seem to do very well in culture medium, RBC will do very little. The authors need a more convincing physiological discussion to motivate the use. It has no relevance to a NMP setting in my opinion.

One of the strengths of the study, that the authors miss, is that the cells can survive for an extented time - much longer than in any whole organ setting. Despite the short warm ischemic setting, the resilience to ischemic insult seem to much better than what is normally considered.

I see the paper as nteresting, but it needs a rewrite with focus on the real use of the method, namely basic science of ischemia and possibly pharmacological manipulation in different settings.

Author Response

See the attachement.

Author Response File: Author Response.pdf

Round 2

Reviewer 2 Report

I have no further comments.

Back to TopTop